240 related articles for article (PubMed ID: 23521457)
1. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
2. Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.
Choi HJ; Kim JK; Ahn H; Kim CS; Kim MH; Cho KS
Acta Radiol; 2011 Apr; 52(3):349-53. PubMed ID: 21498374
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
4. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.
Kim JK; Kim SH; Jang YJ; Ahn H; Kim CS; Park H; Lee JW; Kim S; Cho KS
Radiology; 2006 Apr; 239(1):174-80. PubMed ID: 16507752
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
6. Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
Galmiche C; Bernhard JC; Yacoub M; Ravaud A; Grenier N; Cornelis F
AJR Am J Roentgenol; 2017 Feb; 208(2):343-350. PubMed ID: 27959744
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
8. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
[TBL] [Abstract][Full Text] [Related]
9. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
[TBL] [Abstract][Full Text] [Related]
10. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
[TBL] [Abstract][Full Text] [Related]
12. Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors.
Chung MS; Choi HJ; Kim MH; Cho KS
AJR Am J Roentgenol; 2014 Apr; 202(4):765-71. PubMed ID: 24660704
[TBL] [Abstract][Full Text] [Related]
13. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
[TBL] [Abstract][Full Text] [Related]
17. [Imaging tumor extension of renal cell carcinomas with magnetic resonance tomography. Improved tumor-tissue contrast with Gd-DTPA-assisted spin-echo sequences and simultaneous fat suppression].
Venz S; Hierholzer J; Keske U; Friedrichs R; Schröder R; Siewert C; Hosten N; Felix R
Aktuelle Radiol; 1998 May; 8(3):119-24. PubMed ID: 9645248
[TBL] [Abstract][Full Text] [Related]
18. MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types.
Takeuchi M; Kawai T; Suzuki T; Naiki T; Kawai N; Fujiyoshi Y; Inagaki H; Kohri K; Hara M; Shibamoto Y
Abdom Imaging; 2015 Jan; 40(1):112-9. PubMed ID: 24965897
[TBL] [Abstract][Full Text] [Related]
19. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
20. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
